FTC

U.S. Federal Trade Commission Challenges Private Equity Firm’s Acquisition Spree in Texas

By Christopher Gordon on September 26, 2023 Posted in Antitrust, FTC

On September 21, 2023, the Federal Trade Commission (FTC) filed a lawsuit against U.S. Anesthesia Partners, Inc. (USAP) and private equity firm Welsh, Carson, Anderson & Stowe, alleging that they engaged in anticompetitive practices in the anesthesia services market in Texas. According to the FTC’s complaint, USAP and Welsh Carson executed a multi-year strategy to … Continue Reading

Summer Roundup: Antitrust Agencies Continue Scrutiny of Healthcare Markets and Attain Much Needed Victories

By Kaitlin Rittgers and Christopher Gordon on August 24, 2023 Posted in Accountable Care Organizations, Antitrust, DOJ, FTC, Mergers and Acquisitions, Pharmaceutical

This summer, the Federal Trade Commission (“FTC”) and U.S. Department of Justice (“DOJ”) (together “antitrust agencies” or “agencies”) continued to push boundaries on what constitutes anticompetitive conduct with the withdrawal of key healthcare policy statements and heightened scrutiny of the pharmaceutical industry. This summer also saw the DOJ and FTC score crucial enforcement wins in … Continue Reading